# FDA Inspection 986803 - Puragraft LLC - October 04, 2016

Source: https://www.keypedia.com/records/fda_inspections/puragraft-llc/a9d98538-9ce0-4a4e-ad83-94e460ae687f
Source feed: FDA_Inspections

> FDA Inspection 986803 for Puragraft LLC on October 04, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 986803
- Company Name: Puragraft LLC
- Inspection Date: 2016-10-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1263371 - 2025-03-03](https://www.keypedia.com/records/fda_inspections/puragraft-llc/3aa97d5b-ea1f-427a-980f-cac81fad93b0)
- [FDA Inspection 1263371 - 2025-03-03](https://www.keypedia.com/records/fda_inspections/puragraft-llc/02cf938d-2c29-422e-b53b-9ce528f357b4)
- [FDA Inspection 828251 - 2013-04-19](https://www.keypedia.com/records/fda_inspections/puragraft-llc/43c01431-f3f2-4186-b0d4-f5d13f9c4199)
- [FDA Inspection 622856 - 2009-10-21](https://www.keypedia.com/records/fda_inspections/puragraft-llc/46d2f341-764c-4c14-b8e0-559668ca320a)

Company: https://www.keypedia.com/companies/puragraft-llc/bac71565-11c1-463a-903a-0861e876d23d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d